摘要
目的通过检测支气管哮喘(简称哮喘)患者血浆中自介素33(IL-33)和可溶性ST-2(sST-2)的表达水平,探讨哮喘患者血浆中IL-33和sST-2的作用和临床意义。方法①用ELISA法检测60例哮喘急性发作期患者和20例健康体检者外周血中IL-33和sST-2的血浆浓度。②对所有哮喘患者行肺功能检测(PTF)。③依据FEV1将哮喘患者分为3组:FEV1≥80%或PEF≥80%为轻度哮喘组,60%≤FEV1〈80%或60%≤PEF〈80%中度哮喘组,FEV1〈60%或PEF〈60%为重度哮喘组。结果①轻、中、重度哮喘急性发作期患者血浆中IL-33的水平较正常对照组升高(F=454.81,P=0.00),差异有统计学意义(P〈0.05)。②轻、中、重度哮喘急性发作期患者血浆中sST-2水平较正常对照组升高(F=96.71,P=0.00),差异有统计学意义(P〈O.05)。③哮喘急性发作期患者血浆中IL-33水平与FEV1%pred和PEF均呈明显负相关(P〈0.05)。结论IL-33和sST-2均参与了哮喘的发病过程,其血浆水平的变化可做为病情监测的一项血清学指标,且IL-33可作为重症哮喘和肺功能严重受损的一个标识。
Objective To study the changes of plasma interleukin-33 (IL-33) and its soluble receptor ST-2 (sST-2) in asthmatic patients,and investigate the clinical significance and the effect of IL-33 and sST-2 signal pathway in bronchial asthma (asthma). Methods The plasma levels of IL-33 and its sST-2 were detected by ELISA method in 60 patients with asthma,who were divided into the acute attack group,and 20 healthy controls. Of all patients with asthma pulmonary function test (PTF). ③ According to the pulmonary function (FEV1%pred) in patients with asthma were divided into 3 groups: FEV1≥ 80% and PEF≥80% for mild asthma group, 60≤FEV1〈80%, 60% 〈GPEF〈80% moderate asthma group,FEV1〈60% or PEF〈60% for patients with asthma. Results ①The plasma level of IL-33 with acute exacerbation of asthma in the mild group and moderate group and severe group was markedly increased compared with normal control group ( F = 454.81, P = 0.00), the differences were statistically significant ( P〈0.05). ②The plasma level of sST-2 in acute asthma with acute exacerbation of asthma in the mild group and moderate group and severe group was markedly increased compared with normal control group ( F = 96.71, P = 0.00), the differences were statistically significant ( P 〈0.05). ③The level of IL-33 were negatively correlated with FEV1% pred and PEF of acute exacerbation of asthma ( P 〈0.05). Conclusions IL-33 and its receptor sST-2 were involved in the pathogenesis of asthma,changes to the plasma levels of a serological index for monitoring disease progression,and IL-33 can be used as a sign of severe asthma and lung function is damaged badly.
出处
《国际呼吸杂志》
2015年第11期801-804,共4页
International Journal of Respiration